ANI Pharmaceuticals Newsroom

Guggenheim Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $86

Moomoo NewsApr 12 01:33 ET · Ratings

ANI Pharmaceuticals Price Target Maintained With a $86.00/Share by Guggenheim

Dow JonesApr 11 10:21 ET · Ratings

ANI Pharmaceuticals Analyst Ratings

BenzingaApr 11 10:10 ET · Ratings

AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."

① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.

cls.cnApr 11 07:59 ET

Leerink Partners Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $82

Moomoo NewsApr 10 07:31 ET · Ratings

Press Release: ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 A.m. ET

Dow JonesApr 9 06:50 ET

Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?

Yahoo FinanceApr 7 09:40 ET

ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference

GlobeNewswireMar 31 16:30 ET

Improved Revenues Required Before ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stock's 25% Jump Looks Justified

Simply Wall StMar 28 06:44 ET

Jefferies Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $80

Moomoo NewsMar 27 02:32 ET · Ratings

Strong Growth and Undervaluation Make ANI Pharmaceuticals a Buy

TipRanksMar 26 09:05 ET · Ratings

Hospital Stocks Are Ready to Rebound, Deutsche Bank Says

BNN BloombergMar 25 13:51 ET

Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com

Barron'sMar 25 00:01 ET

Is ANI (ANIP) a Solid Growth Stock? 3 Reasons to Think "Yes"

Zacks Mar 24 11:55 ET

ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets

GlobeNewswireMar 19 06:50 ET

ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN and YUTIQ

GlobeNewswireMar 18 06:50 ET

The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.

Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.

Zhitong FinanceMar 18 03:00 ET

H.C. Wainwright Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $94

Moomoo NewsMar 18 02:31 ET · Ratings

New York Manufacturing Hits Low, Inflation Fears Rise

InvestingMar 17 08:50 ET

HC Wainwright & Co. Reiterates Buy on ANI Pharmaceuticals, Maintains $94 Price Target

BenzingaMar 17 06:50 ET · Ratings